Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28799
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorBarone, D.-
dc.contributor.authorBroadley, S.-
dc.contributor.authorDive, D.-
dc.contributor.authorHupperts, R. M. M.-
dc.contributor.authorLycke, J.-
dc.contributor.authorMassacesi, L.-
dc.contributor.authorMontalban, X.-
dc.contributor.authorNaismith, R. T.-
dc.contributor.authorPandey, K.-
dc.contributor.authorSchippling, S.-
dc.contributor.authorVermersch, P.-
dc.contributor.authorChung, L.-
dc.contributor.authorDaizadeh, N.-
dc.contributor.authorRodriguez, C. E.-
dc.contributor.authorNakamura, K.-
dc.contributor.authorWiendl, H.-
dc.date.accessioned2019-07-24T12:56:03Z-
dc.date.available2019-07-24T12:56:03Z-
dc.date.issued2018-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 24, p. 488-489-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/28799-
dc.description.sponsorshipSanofi; Bayer HealthCare Pharmaceuticals-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.subject.otherClinical Neurology; Neurosciences-
dc.titleAlemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study)-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 10-12, 2018-
local.bibliographicCitation.conferencename34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceBerlin, GERMANY-
dc.identifier.epage489-
dc.identifier.spage488-
dc.identifier.volume24-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Centre Overpelt, Hasselt, Belgium. [Barone, D.] Rowan Univ, Glassboro, NJ USA. [Broadley, S.] Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld, Australia. [Dive, D.] Univ Hosp Ctr Liege, Liege, Belgium. [Hupperts, R. M. M.] Maastricht Univ, Med Ctr, Orbis Med Ctr, Sittard, Netherlands. [Lycke, J.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden. [Massacesi, L.] Univ Florence, Florence, Italy. [Montalban, X.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, X.] Hosp Univ Vall dHebron, Ctr Esclerosi Mfiltiple Catalunya Cemcat, Barcelona, Spain. [Naismith, R. T.] Washington Univ, Sch Med, St Louis, MO USA. [Pandey, K.] Hackensack Univ Hosp, Multiple Sclerosis Care Ctr, Hackensack, NJ USA. [Schippling, S.] Univ Hosp Zurich, Neuroimmunol & Multiple Sclerosis Res, Zurich, Switzerland. [Schippling, S.] Univ Zurich, Zurich, Switzerland. [Vermersch, P.] Univ Lille, Lille, France. [Chung, L.; Daizadeh, N.; Rodriguez, C. E.] Sanofi, Cambridge, MA USA. [Nakamura, K.] Cleveland Clin, Cleveland, OH 44106 USA. [Wiendl, H.] Univ Munster, Munster, Germany.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000446861401257-
item.fulltextNo Fulltext-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorBarone, D.-
item.contributorBroadley, S.-
item.contributorDive, D.-
item.contributorHupperts, R. M. M.-
item.contributorLycke, J.-
item.contributorMassacesi, L.-
item.contributorMontalban, X.-
item.contributorNaismith, R. T.-
item.contributorPandey, K.-
item.contributorSchippling, S.-
item.contributorVermersch, P.-
item.contributorChung, L.-
item.contributorDaizadeh, N.-
item.contributorRodriguez, C. E.-
item.contributorNakamura, K.-
item.contributorWiendl, H.-
item.fullcitationVAN WIJMEERSCH, Bart; Barone, D.; Broadley, S.; Dive, D.; Hupperts, R. M. M.; Lycke, J.; Massacesi, L.; Montalban, X.; Naismith, R. T.; Pandey, K.; Schippling, S.; Vermersch, P.; Chung, L.; Daizadeh, N.; Rodriguez, C. E.; Nakamura, K. & Wiendl, H. (2018) Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study). In: MULTIPLE SCLEROSIS JOURNAL, 24, p. 488-489.-
item.accessRightsClosed Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.